Launching a crypto token used to mean months of coding, audits, and expensive marketing. Clarnium changes that.Launching a crypto token used to mean months of coding, audits, and expensive marketing. Clarnium changes that.

Clarnium: Launch Tokens, Grow Communities, and Scale Faster with AI

2025/10/27 19:18
4 min read

Launching a crypto token used to mean months of coding, audits, and expensive marketing. Clarnium changes that. With its core platform ClarFun, anyone can bring a new token to life in just three clicks. No technical background, no big budget, no delays.

Whether you’re a creator looking to test an idea or a degen hunting for early opportunities, ClarFun is where AI meets tokenization. It’s fast, automated, and built to help projects grow from zero to traction in record time.

Clarnium 

Clarnium is a full ecosystem for token creation, growth, and monetization. It brings together various interconnected products:

  • ClarPay for crypto payments,

  • SocialFi Platform for engagement,

  • Marketplace for digital assets,

  • Clarnium Media for exposure,

  • Alpha DAO, the capital-backed community supporting liquidity and growth for the best-performing projects,

  • and at the center — ClarFun, the no-code token launcher.

ClarFun lets anyone create and deploy a token instantly, then use integrated tools to promote it. Each project gets access to AI agents, airdrop campaigns, and quest constructors. In other words, there's everything needed to attract attention and turn users around new projects into real communities.

Why Teams Choose Clarnium

Launching a token can be costly and time-consuming. Clarnium eliminates both problems.

With ready-to-use smart contract templates and deployment on the Base network (Solana integration coming soon), creators can go live instantly, saving weeks of development and thousands of dollars. Even solo founders can handle a full token launch including tech and liquidity support and marketing strategies, all of it within one ecosystem.

Every stage of the launch process is powered by AI automation. Intelligent agents manage marketing tasks through platforms like Grok and X API, multiplying reach and traffic by up to 10x. The built-in AI marketing tools act like a 24/7 social media manager, increasing visibility and engagement without extra staff or budget. For small teams, this means big-league exposure at minimal cost.

An upcoming Website Creation service will allow founders to design custom landing pages without code. These pages will explain the project, link socials and quests, display campaign stats, and onboard new users. 

ClarFun also features a quest-based engagement layer. Users perform simple tasks such as follow, repost, or engage with content to earn airdrops.

To solve the liquidity challenge faced by most new tokens, Clarnium integrates Alpha DAO — a private, capital-backed collective that supports high-potential projects. The DAO helps provide liquidity and marketing support, ensuring tokens don’t just launch, but actually trade.

Power of Alpha DAO

Alpha DAO is the investment and support layer within the Clarnium ecosystem. Through the ClarFun AI Grant program, selected projects can receive liquidity and ecosystem backing. Participation is open but selective. To join, users need CLAR tokens.

Alpha DAO acts as the growth engine for Clarnium, connecting serious builders with active supporters who fund, trade, and promote promising new tokens.

Getting CLAR Tokens

There are two ways to earn $CLAR, the native Clarnium token:

  • Presale Participation, held in ten rounds. The next round opens soon. To join, connect your wallet at the official sale site and pick your preferred network — Solana, Ethereum, BSC, Polygon, Base, Tron, TON, Optimism, Arbitrum, or Avalanche. Investment ranges from $50 to $10,000, with payments accepted in USDT, USDC, ETH, SOL, and other cryptocurrencies. All transactions are executed via smart contracts. Tokens will be distributed during the Token Generation Event (TGE).

  • Airdrop Program. Allows earning synthetic xCLAR tokens for social engagement, inviting friends, trading on ClarFun, or completing daily quests. These xCLAR rewards will convert to real $CLAR closer to the TGE date. Users can open xCLAR boxes every 8 hours, each holding 1,000–5,000 tokens. The Auto-Farm feature collects them automatically, ensuring no rewards are missed.

ClarFun is currently in beta, with a full public launch planned for Q4 2025, and AI Agents rolling out in Q1 2026.

Transparent Team 

Clarnium is developed by an open, public team led by Andrew Furman, a tech entrepreneur with over 15 years in blockchain and Web3 product development. The project is co-built with LazyAnts, a leading European Web3 studio with more than 800 delivered projects, 16 years of experience, and 100+ professionals. Their track record includes Deutsche Bank, Robert Bosch Stiftung, and Dertour Group.

Clarnium also collaborates with major industry partners such as Polygon, Arbitrum, Blockchain Game Alliance, Seedify, Footprint Analytics, and more than 56 Web3 game studios, including Star Atlas, Cantina Royale, and Apeiron.

Follow Clarnium for the latest updates, airdrops, and early access to the next generation of AI-powered crypto projects.

Disclaimer: This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

Market Opportunity
null Logo
null Price(null)
--
----
USD
null (null) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26